93 results
8-K
EX-99.1
DNTH
Dianthus Therapeutics Inc
24 Jun 19
Magenta Therapeutics Appoints Anne McGeorge to Board of Directors
4:48pm
Therapeutics. “Ms. McGeorge has extensive financial and strategic leadership experience in healthcare. Her diverse expertise will be invaluable to Magenta … .”
Ms. McGeorge is an operating partner at Havencrest Healthcare, a growth equity fund specializing in the healthcare industry; and a board member
8-K/A
EX-99.2
DNTH
Dianthus Therapeutics Inc
20 Sep 23
Results of Operations and Financial Condition
9:50pm
LLC (“Fairmount”), Fidelity Management & Research Company, Tellus BioVentures, LLC (“Tellus BioVentures”) and Venrock Healthcare Capital Partners … -funded warrants from a syndicate of healthcare investors led by Fidelity Management & Research Company, Catalio Capital Management, 5AM Ventures, Avidity
8-K
EX-99.1
DNTH
Dianthus Therapeutics Inc
3 May 23
Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement
7:44am
and pre-funded warrants from a syndicate of healthcare investors led by Fidelity Management & Research Company, Catalio Capital Management, 5AM Ventures … , Avidity Partners, Wedbush Healthcare Partners and founding investors Fairmount, Tellus BioVentures and Venrock Healthcare Capital Partners
8-K
DNTH
Dianthus Therapeutics Inc
24 Jun 19
Magenta Therapeutics Appoints Anne McGeorge to Board of Directors
4:48pm
oversight to health care organizations. Ms. McGeorge currently works as an operating partner for Havencrest Healthcare Partners and as an adjunct … . McGeorge worked at Grant Thornton LLP where she routinely advised clients on audit and financial matters relating to the healthcare industry. During her
8-K
EX-99.1
clerjidmz
8 Aug 19
Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
8:13am
10-Q
avfyqqeib1nrahqz a5t
9 Aug 18
Quarterly report
4:21pm
8-K
EX-99.1
wacy87mp4udvwhfdw8it
9 Nov 23
Dianthus Therapeutics Highlights Recent Business Achievements and Third Quarter 2023 Financial Results
4:09pm
10-K
xq2p p6cyk65bx98t
19 Mar 19
Annual report
7:44am